Showing 1 of 1 PublicationsWhy Biologic Therapies Sometimes Lose Efficacy.Strober B. Why Biologic Therapies Sometimes Lose Efficacy. Seminars In Cutaneous Medicine And Surgery 2016, 35: s78-80. PMID: 27525443, DOI: 10.12788/j.sder.2016.022.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsMeSH KeywordsAdalimumabBiological ProductsClinical Trials as TopicDermatologic AgentsDrug Therapy, CombinationEvidence-Based MedicineHumansImmunosuppressive AgentsPsoriasisTreatment OutcomeConceptsBiologic therapyLow serum drug levelsSerum drug levelsLoss of responseEpisodic therapyClinical responseSuboptimal dosingImmunomodulatory agentsDrug levelsTherapyRisk of immunogenicityImmunogenicityPsoriasisDosingResponseDownload Full List
Why Biologic Therapies Sometimes Lose Efficacy.Strober B. Why Biologic Therapies Sometimes Lose Efficacy. Seminars In Cutaneous Medicine And Surgery 2016, 35: s78-80. PMID: 27525443, DOI: 10.12788/j.sder.2016.022.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsMeSH KeywordsAdalimumabBiological ProductsClinical Trials as TopicDermatologic AgentsDrug Therapy, CombinationEvidence-Based MedicineHumansImmunosuppressive AgentsPsoriasisTreatment OutcomeConceptsBiologic therapyLow serum drug levelsSerum drug levelsLoss of responseEpisodic therapyClinical responseSuboptimal dosingImmunomodulatory agentsDrug levelsTherapyRisk of immunogenicityImmunogenicityPsoriasisDosingResponse